Release date: 2024-12-31 11:20:04 Recommended: 66
Ensidipine should be stored at room temperature, the generally recommended temperature range is 15-30 ° C. Avoid storing medicines in environments with extreme temperatures, such as refrigerators or places with high temperatures. Extreme temperatures can affect the stability of a drug.
Ensidipine should be stored in a dry environment, protected from moisture, to prevent its quality from being affected. The medicine should be kept in a cool, dark place and avoid direct exposure to sunlight. Direct sunlight and high temperatures may accelerate drug degradation.
Ensidipine should be stored in its original sealed packaging and avoid exposure to air to prevent oxidation or other adverse environmental influences. Check the integrity of the package regularly and contact your doctor or pharmacist immediately if it is damaged.
Ensidipine should be taken at a fixed time every day to ensure a stable concentration of the drug in the body. This helps to maintain the effectiveness of the treatment and reduce adverse effects due to missed or overdosed. When taking the tablet, it should be swallowed whole, and avoid chewing or breaking the tablet, as this may affect the efficacy of the drug or increase the risk of adverse reactions.
Patients should have regular follow-up appointments as recommended by their doctor to monitor the effectiveness of treatment and physical condition. Your doctor may adjust the dose or do other tests as needed. In case of any discomfort or serious side effects, the patient should inform the doctor promptly so that the necessary measures can be taken.
Before taking ensidipine, patients should inform their doctor about other medications they are taking, as some drugs may interact with encidipine, affecting its efficacy or increasing the risk of adverse effects. For example, encidipine may interact with a variety of drugs, particularly substrates for CYP1A2, CYP2C19, CYP3A, OATP1B1, OATP1B3, BCRP, and P-gp, caffeine intake should be reduced frequently, and other contraceptive methods should be considered for hormonal contraceptive use.
Pregnant and lactating women should avoid encidipine because its safety for the fetus and infant has not been established. Women of childbearing potential and their partners should use effective contraception during treatment and for 2 months after discontinuation.
The safety of the drug in children and older adults has not been fully established and should be used with caution. Before using encidipine, a doctor should be consulted and the dose adjusted according to the specific situation of the patient.
Encidipine is metabolized mainly by the liver, and patients with impaired liver function need special attention to dose adjustment. The doctor may adjust the dose according to the patient's liver function status to avoid the drug building up in the body and causing toxic reactions.
Ensidipine is a product that is used under special conditions, and its storage and use require strict compliance with relevant precautions. Patients should maintain close communication with their doctor during the use of encidipine and strictly follow the doctor's instructions.